Maynard Um
-
-
-
-
-
-
-
Coya Therapeutics publishes study linking ALS biomarkers to survival
-
-
-
-
-
-
-
FDA accepts Coya Therapeutics IND for dementia treatment COYA 302
-
-
-
-
-
-
-
Coya Therapeutics (COYA) Shares Up As Greenlight Says It's The Largest Shareholder - Bloomberg
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Coya Therapeutics (COYA)
-
-
-
-
-
-
-
Coya Therapeutics (COYA) Issues New US Patent Protecting Methods of Producing Recombinant Human Interleukin-2 Liquid Formulations
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Coya Therapeutics (COYA)
-
-
-
-
-
-
-
Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 10c
-
466,309 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


